Global Pharmaceutical Market Forecast to 2012
Single User PDF Format: US$ 1,600.00
Multi-User License: US$ 2,400.00
Hard Copy: US$ 1,800.00
CD-ROM: US$ 1,800.00
The pharmaceutical market worldwide, after experiencing a slump during the past 2 years, is now in its recovery period, which will be followed by its growth. Decline in global pharma market was largely due to the economic slowdown, and further aggravated by patent expiry of key blockbusters together with saturation in key pharma markets, such as the US and Western Europe. Meanwhile, pharma markets in some developing regions, like Asia and Latin America have been continuously witnessing robust growth rate for the last few years on account of increasing prevalence of diseases, rising healthcare spending, and increasing affordability. Overall, these markets will enjoy good growth potential in coming few years.
According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6.5% during 2011-2013. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide, and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market during the forecast period, indicating large opportunities for generics manufacturers to tap.
Our regional level analysis found that the pharma industry is growing at a rapid rate in emerging countries, such as India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides, we have found that growing inorganically via means of mergers & acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenue. We anticipate this trend to continue in near future also.
“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and MENA have been selected as the most important regions to be discussed in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
Multi-User License: US$ 2,400.00
Hard Copy: US$ 1,800.00
CD-ROM: US$ 1,800.00
The pharmaceutical market worldwide, after experiencing a slump during the past 2 years, is now in its recovery period, which will be followed by its growth. Decline in global pharma market was largely due to the economic slowdown, and further aggravated by patent expiry of key blockbusters together with saturation in key pharma markets, such as the US and Western Europe. Meanwhile, pharma markets in some developing regions, like Asia and Latin America have been continuously witnessing robust growth rate for the last few years on account of increasing prevalence of diseases, rising healthcare spending, and increasing affordability. Overall, these markets will enjoy good growth potential in coming few years.
According to our latest research “Global Pharmaceutical Market Forecast to 2012”, global pharma industry is projected to grow at a CAGR of around 6.5% during 2011-2013. The growth will be driven by low cost factor, increasing prevalence of diseases worldwide, and rising per capita income of consumers. Our research identifies that sales of generic drugs will emerge as the most prominent segment of the pharma market during the forecast period, indicating large opportunities for generics manufacturers to tap.
Our regional level analysis found that the pharma industry is growing at a rapid rate in emerging countries, such as India, China, Brazil, Russia, among others, while a slowdown in the growth has been encountered in the US and Western European countries. Besides, we have found that growing inorganically via means of mergers & acquisitions has emerged as the most viable way for the companies to expand/extend their reach at a faster rate and maintain their revenue. We anticipate this trend to continue in near future also.
“Global Pharmaceutical Market Forecast to 2012” provides a comprehensive analysis of every major pharmaceutical market worldwide. North America, Latin America, Europe, Asia-Pacific, and MENA have been selected as the most important regions to be discussed in this report. The report contains statistical and analytical information on each of these markets, covering their current market size, demand, and healthcare statistics. It also features analysis of future directions, supplemented with facts and figures.
1. ANALYST VIEW
2. GLOBAL PHARMACEUTICAL MARKET: AN OVERVIEW
2.1 Market Size & Growth
2.2 Geographical Performance
2.3 Leading Therapy Classes
2.4 Leading Drugs
2.5 Leading Pharmaceutical Companies
3. MARKET BY REGION
3.1 North America
3.1.1 US
3.1.2 Canada
3.2 Latin America
3.2.1 Brazil
3.2.2 Mexico
3.2.3 Argentina
3.2.4 Chile
3.3 Europe
3.3.1 Germany
3.3.2 France
3.3.3 Italy
3.3.4 Spain
3.3.5 UK
3.3.6 Russia
3.3.7 Turkey
3.3.8 Poland
3.3.9 Hungary
3.3.10 Ukraine
3.3.11 Czech Republic
3.3.12 Romania
3.4 Asia-Pacific
3.4.1 India
3.4.2 China
3.4.3 Japan
3.4.4 South Korea
3.4.5 Indonesia
3.4.6 Vietnam
3.4.7 Thailand
3.4.8 Philippines
3.4.9 Malaysia
3.4.10 Australia
3.4.11 New Zealand
3.5 MENA
3.5.1 Saudi Arabia
3.5.2 UAE
3.5.3 South Africa
3.5.4 Egypt
3.5.5 Nigeria
4. KEY PLAYER PROFILES
4.1 Pfizer Inc
4.2 Sanofi-Aventis
4.3 GlaxoSmithKline plc
4.4 Novartis International AG
4.5 AstraZeneca Plc
2. GLOBAL PHARMACEUTICAL MARKET: AN OVERVIEW
2.1 Market Size & Growth
2.2 Geographical Performance
2.3 Leading Therapy Classes
2.4 Leading Drugs
2.5 Leading Pharmaceutical Companies
3. MARKET BY REGION
3.1 North America
3.1.1 US
3.1.2 Canada
3.2 Latin America
3.2.1 Brazil
3.2.2 Mexico
3.2.3 Argentina
3.2.4 Chile
3.3 Europe
3.3.1 Germany
3.3.2 France
3.3.3 Italy
3.3.4 Spain
3.3.5 UK
3.3.6 Russia
3.3.7 Turkey
3.3.8 Poland
3.3.9 Hungary
3.3.10 Ukraine
3.3.11 Czech Republic
3.3.12 Romania
3.4 Asia-Pacific
3.4.1 India
3.4.2 China
3.4.3 Japan
3.4.4 South Korea
3.4.5 Indonesia
3.4.6 Vietnam
3.4.7 Thailand
3.4.8 Philippines
3.4.9 Malaysia
3.4.10 Australia
3.4.11 New Zealand
3.5 MENA
3.5.1 Saudi Arabia
3.5.2 UAE
3.5.3 South Africa
3.5.4 Egypt
3.5.5 Nigeria
4. KEY PLAYER PROFILES
4.1 Pfizer Inc
4.2 Sanofi-Aventis
4.3 GlaxoSmithKline plc
4.4 Novartis International AG
4.5 AstraZeneca Plc
LIST OF FIGURES:
Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2008-2010
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2008-2010
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2009
Figure 2-5: Global – Revenue of Leading Pharmaceutical Companies (Billion US$), 2009
Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-3: US - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2008-2010
Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2011-2013
Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-15: Chile - Pharmaceutical Market (Million US$), 2008-2010
Figure 3-16: Chile - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-19: Germany - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-20: Germany - Share of Export in Pharmaceutical Market (2009)
Figure 3-21: Germany - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-22: France - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-23: France - Share of Generics and Branded Drugs in Pharmaceutical Market (2009)
Figure 3-24: France - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-25: Italy - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-26: Italy - Share of Prescription and Non-Prescription Drugs in Pharmaceutical Market (2009)
Figure 3-27: Italy - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-28: Spain - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-29: Spain - Share of Prescription and OTC Drugs in Pharmaceutical Market (2010)
Figure 3-30: Spain - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-31: UK - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-32: UK - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-33: Russia - Pharmaceutical Market (Billion Rubles), 2008-2010
Figure 3-34: Russia - Share of Commercial and State Sector in Pharmaceutical Market (2009)
Figure 3-35: Russia - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market
Figure 3-36: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2011-2013
Figure 3-37: Turkey - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-38: Turkey - Share of Branded and Generic Drugs in Pharmaceutical Market (2009)
Figure 3-39: Turkey - Share of Therapy Areas in Pharmaceutical Market (2009)
Figure 3-40: Turkey - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market (2009)
Figure 3-41: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-42: Poland - Pharmaceutical Market (Billion PLN), 2008-2010
Figure 3-43: Poland - Forecast for Pharmaceutical Market (Billion PLN), 2011-2013
Figure 3-44: Hungary - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-45: Hungary - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-46: Ukraine - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-47: Ukraine - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-48: Czech Republic - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-49: Czech Republic - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-50: Romania - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-51: Romania - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-52: Asia-Pacific - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-53: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-54: India - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-55: India - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-56: China - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-57: China - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-58: Japan - Pharmaceutical Market (Trillion JPY), 2008-2010
Figure 3-59: Japan - Forecast for Pharmaceutical Market (Trillion JPY), 2011-2013
Figure 3-60: South Korea - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-61: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-62: Indonesia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-63: Indonesia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-64: Vietnam - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-65: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-66: Thailand - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-67: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-68: Philippines - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-69: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-70: Malaysia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-71: Malaysia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-72: Australia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-73: Australia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-74: New Zealand - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-75: New Zealand - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-76: Saudi Arabia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-77: Saudi Arabia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-78: UAE - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-79: UAE - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-80: South Africa - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-81: South Africa - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-82: Egypt - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-83: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-84: Nigeria - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-85: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 2-1: Global - Pharmaceutical Market (Billion US$), 2008-2010
Figure 2-2: Global - Growth in Pharmaceutical Market (%), 2008-2010
Figure 2-3: Global - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 2-4: Global - Pharmaceutical Market by Region (%), 2009
Figure 2-5: Global – Revenue of Leading Pharmaceutical Companies (Billion US$), 2009
Figure 3-1: North America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-2: North America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-3: US - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-4: US - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-5: Canada - Pharmaceutical Market (Billion CAD), 2008-2010
Figure 3-6: Canada - Forecast for Pharmaceutical Market (Billion CAD), 2011-2013
Figure 3-7: Latin America - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-8: Latin America - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-9: Brazil - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-10: Brazil - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-11: Mexico - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-12: Mexico - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-13: Argentina - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-14: Argentina - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-15: Chile - Pharmaceutical Market (Million US$), 2008-2010
Figure 3-16: Chile - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-17: Europe - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-18: Europe - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-19: Germany - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-20: Germany - Share of Export in Pharmaceutical Market (2009)
Figure 3-21: Germany - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-22: France - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-23: France - Share of Generics and Branded Drugs in Pharmaceutical Market (2009)
Figure 3-24: France - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-25: Italy - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-26: Italy - Share of Prescription and Non-Prescription Drugs in Pharmaceutical Market (2009)
Figure 3-27: Italy - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-28: Spain - Pharmaceutical Market (Billion Euro), 2008-2010
Figure 3-29: Spain - Share of Prescription and OTC Drugs in Pharmaceutical Market (2010)
Figure 3-30: Spain - Forecast for Pharmaceutical Market (Billion Euro), 2011-2013
Figure 3-31: UK - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-32: UK - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-33: Russia - Pharmaceutical Market (Billion Rubles), 2008-2010
Figure 3-34: Russia - Share of Commercial and State Sector in Pharmaceutical Market (2009)
Figure 3-35: Russia - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market
Figure 3-36: Russia - Forecast for Pharmaceutical Market (Billion Rubles), 2011-2013
Figure 3-37: Turkey - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-38: Turkey - Share of Branded and Generic Drugs in Pharmaceutical Market (2009)
Figure 3-39: Turkey - Share of Therapy Areas in Pharmaceutical Market (2009)
Figure 3-40: Turkey - Share of Imported and Domestically-produced Drugs in Pharmaceutical Market (2009)
Figure 3-41: Turkey - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-42: Poland - Pharmaceutical Market (Billion PLN), 2008-2010
Figure 3-43: Poland - Forecast for Pharmaceutical Market (Billion PLN), 2011-2013
Figure 3-44: Hungary - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-45: Hungary - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-46: Ukraine - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-47: Ukraine - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-48: Czech Republic - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-49: Czech Republic - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-50: Romania - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-51: Romania - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-52: Asia-Pacific - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-53: Asia-Pacific - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-54: India - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-55: India - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-56: China - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-57: China - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-58: Japan - Pharmaceutical Market (Trillion JPY), 2008-2010
Figure 3-59: Japan - Forecast for Pharmaceutical Market (Trillion JPY), 2011-2013
Figure 3-60: South Korea - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-61: South Korea - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-62: Indonesia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-63: Indonesia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-64: Vietnam - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-65: Vietnam - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-66: Thailand - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-67: Thailand - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-68: Philippines - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-69: Philippines - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-70: Malaysia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-71: Malaysia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-72: Australia - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-73: Australia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-74: New Zealand - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-75: New Zealand - Forecast for Pharmaceutical Market (Million US$), 2011-2013
Figure 3-76: Saudi Arabia - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-77: Saudi Arabia - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-78: UAE - Pharmaceutical Market (Billion US$), 2009 & 2010
Figure 3-79: UAE - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-80: South Africa - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-81: South Africa - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-82: Egypt - Pharmaceutical Market (Billion US$), 2008-2010
Figure 3-83: Egypt - Forecast for Pharmaceutical Market (Billion US$), 2011-2013
Figure 3-84: Nigeria - Pharmaceutical Market (Million US$), 2009 & 2010
Figure 3-85: Nigeria - Forecast for Pharmaceutical Market (Million US$), 2011-2013
LIST OF TABLES:
Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2009
Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2009
Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2009
Table 3-1: US - Healthcare Statistics (2008-2010)
Table 3-2: US - Forecast for Healthcare Statistics (2011-2013)
Table 3-3: Canada - Healthcare Statistics (2008-2010)
Table 3-4: Canada - Forecast for Healthcare Statistics (2011-2013)
Table 3-5: Brazil - Healthcare Statistics (2008-2010)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2011-2013)
Table 3-7: Mexico - Healthcare Statistics (2008-2010)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2011-2013)
Table 3-9: Argentina - Healthcare Statistics (2008-2010)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2011-2013)
Table 3-11: Chile - Healthcare Statistics (2008-2010)
Table 3-12: Chile - Forecast for Healthcare Statistics (2011-2013)
Table 3-13: Germany - Healthcare Statistics (2008-2010)
Table 3-14: Germany - Forecast for Healthcare Statistics (2011-2013)
Table 3-15: France - Healthcare Statistics (2008-2010)
Table 3-16: France - Forecast for Healthcare Statistics (2011-2013)
Table 3-17: Italy - Healthcare Statistics (2008-2010)
Table 3-18: Italy - Forecast for Healthcare Statistics (2011-2013)
Table 3-19: Spain - Healthcare Statistics (2008-2010)
Table 3-20: Spain - Forecast for Healthcare Statistics (2011-2013)
Table 3-21: UK - Healthcare Statistics (2008-2010)
Table 3-22: UK - Forecast for Healthcare Statistics (2011-2013)
Table 3-23: Russia - Healthcare Statistics (2008-2010)
Table 3-24: Russia - Forecast for Healthcare Statistics (2011-2013)
Table 3-25: Turkey - Healthcare Statistics (2008-2010)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2011-2013)
Table 3-27: Poland - Healthcare Statistics (2008-2010)
Table 3-28: Poland - Forecast for Healthcare Statistics (2011-2013)
Table 3-29: Hungary - Healthcare Statistics (2008-2010)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2011-2013)
Table 3-31: Ukraine - Healthcare Statistics (2008-2010)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2011-2013)
Table 3-33: Czech Republic - Healthcare Statistics (2008-2010)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2011-2013)
Table 3-35: Romania - Healthcare Statistics (2008-2010)
Table 3-36: Romania - Forecast for Healthcare Statistics (2011-2013)
Table 3-37: India - Healthcare Statistics (2008-2010)
Table 3-38: India - Forecast for Healthcare Statistics (2011-2013)
Table 3-39: China - Healthcare Statistics (2008-2010)
Table 3-40: China - Forecast for Healthcare Statistics (2011-2013)
Table 3-41: Japan - Healthcare Statistics (2008-2010)
Table 3-42: Japan - Forecast for Healthcare Statistics (2011-2013)
Table 3-43: South Korea - Healthcare Statistics (2008-2010)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2011-2013)
Table 3-45: Indonesia - Healthcare Statistics (2008-2010)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2011-2013)
Table 3-47: Vietnam - Healthcare Statistics (2008-2010)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2011-2013)
Table 3-49: Thailand - Healthcare Statistics (2008-2010)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2011-2013)
Table 3-51: Philippines - Healthcare Statistics (2008-2010)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2011-2013)
Table 3-53: Malaysia - Healthcare Statistics (2008-2010)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2011-2013)
Table 3-55: Australia - Healthcare Statistics (2008-2010)
Table 3-56: Australia - Forecast for Healthcare Statistics (2011-2013)
Table 3-57: New Zealand - Healthcare Statistics (2008-2010)
Table 3-58: New Zealand - Forecast for Healthcare Statistics (2011-2013)
Table 3-59: Saudi Arabia - Healthcare Statistics (2008-2010)
Table 3-60: Saudi Arabia - Forecast for Healthcare Statistics (2011-2013)
Table 3-61: South Africa - Healthcare Statistics (2008-2010)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2011-2013)
Table 3-63: Egypt - Healthcare Statistics (2008-2010)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2011-2013)
Table 3-65: Nigeria - Healthcare Statistics (2008-2010)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2011-2013)
Table 4-1: Pfizer Inc - Strengths & Weaknesses
Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-4: Novartis International AG - Strengths & Weaknesses
Table 4-5: AstraZeneca Plc - Strengths & Weaknesse
Table 2-1: Global - Pharmaceutical Market by Region (Billion US$), 2009
Table 2-2: Global - Leading Therapy Classes by Sales (Billion US$), 2009
Table 2-3: Global - Leading Drugs by Sales (Billion US$), 2009
Table 3-1: US - Healthcare Statistics (2008-2010)
Table 3-2: US - Forecast for Healthcare Statistics (2011-2013)
Table 3-3: Canada - Healthcare Statistics (2008-2010)
Table 3-4: Canada - Forecast for Healthcare Statistics (2011-2013)
Table 3-5: Brazil - Healthcare Statistics (2008-2010)
Table 3-6: Brazil - Forecast for Healthcare Statistics (2011-2013)
Table 3-7: Mexico - Healthcare Statistics (2008-2010)
Table 3-8: Mexico - Forecast for Healthcare Statistics (2011-2013)
Table 3-9: Argentina - Healthcare Statistics (2008-2010)
Table 3-10: Argentina - Forecast for Healthcare Statistics (2011-2013)
Table 3-11: Chile - Healthcare Statistics (2008-2010)
Table 3-12: Chile - Forecast for Healthcare Statistics (2011-2013)
Table 3-13: Germany - Healthcare Statistics (2008-2010)
Table 3-14: Germany - Forecast for Healthcare Statistics (2011-2013)
Table 3-15: France - Healthcare Statistics (2008-2010)
Table 3-16: France - Forecast for Healthcare Statistics (2011-2013)
Table 3-17: Italy - Healthcare Statistics (2008-2010)
Table 3-18: Italy - Forecast for Healthcare Statistics (2011-2013)
Table 3-19: Spain - Healthcare Statistics (2008-2010)
Table 3-20: Spain - Forecast for Healthcare Statistics (2011-2013)
Table 3-21: UK - Healthcare Statistics (2008-2010)
Table 3-22: UK - Forecast for Healthcare Statistics (2011-2013)
Table 3-23: Russia - Healthcare Statistics (2008-2010)
Table 3-24: Russia - Forecast for Healthcare Statistics (2011-2013)
Table 3-25: Turkey - Healthcare Statistics (2008-2010)
Table 3-26: Turkey - Forecast for Healthcare Statistics (2011-2013)
Table 3-27: Poland - Healthcare Statistics (2008-2010)
Table 3-28: Poland - Forecast for Healthcare Statistics (2011-2013)
Table 3-29: Hungary - Healthcare Statistics (2008-2010)
Table 3-30: Hungary - Forecast for Healthcare Statistics (2011-2013)
Table 3-31: Ukraine - Healthcare Statistics (2008-2010)
Table 3-32: Ukraine - Forecast for Healthcare Statistics (2011-2013)
Table 3-33: Czech Republic - Healthcare Statistics (2008-2010)
Table 3-34: Czech Republic - Forecast for Healthcare Statistics (2011-2013)
Table 3-35: Romania - Healthcare Statistics (2008-2010)
Table 3-36: Romania - Forecast for Healthcare Statistics (2011-2013)
Table 3-37: India - Healthcare Statistics (2008-2010)
Table 3-38: India - Forecast for Healthcare Statistics (2011-2013)
Table 3-39: China - Healthcare Statistics (2008-2010)
Table 3-40: China - Forecast for Healthcare Statistics (2011-2013)
Table 3-41: Japan - Healthcare Statistics (2008-2010)
Table 3-42: Japan - Forecast for Healthcare Statistics (2011-2013)
Table 3-43: South Korea - Healthcare Statistics (2008-2010)
Table 3-44: South Korea - Forecast for Healthcare Statistics (2011-2013)
Table 3-45: Indonesia - Healthcare Statistics (2008-2010)
Table 3-46: Indonesia - Forecast for Healthcare Statistics (2011-2013)
Table 3-47: Vietnam - Healthcare Statistics (2008-2010)
Table 3-48: Vietnam - Forecast for Healthcare Statistics (2011-2013)
Table 3-49: Thailand - Healthcare Statistics (2008-2010)
Table 3-50: Thailand - Forecast for Healthcare Statistics (2011-2013)
Table 3-51: Philippines - Healthcare Statistics (2008-2010)
Table 3-52: Philippines - Forecast for Healthcare Statistics (2011-2013)
Table 3-53: Malaysia - Healthcare Statistics (2008-2010)
Table 3-54: Malaysia - Forecast for Healthcare Statistics (2011-2013)
Table 3-55: Australia - Healthcare Statistics (2008-2010)
Table 3-56: Australia - Forecast for Healthcare Statistics (2011-2013)
Table 3-57: New Zealand - Healthcare Statistics (2008-2010)
Table 3-58: New Zealand - Forecast for Healthcare Statistics (2011-2013)
Table 3-59: Saudi Arabia - Healthcare Statistics (2008-2010)
Table 3-60: Saudi Arabia - Forecast for Healthcare Statistics (2011-2013)
Table 3-61: South Africa - Healthcare Statistics (2008-2010)
Table 3-62: South Africa - Forecast for Healthcare Statistics (2011-2013)
Table 3-63: Egypt - Healthcare Statistics (2008-2010)
Table 3-64: Egypt - Forecast for Healthcare Statistics (2011-2013)
Table 3-65: Nigeria - Healthcare Statistics (2008-2010)
Table 3-66: Nigeria - Forecast for Healthcare Statistics (2011-2013)
Table 4-1: Pfizer Inc - Strengths & Weaknesses
Table 4-2: Sanofi-Aventis - Strengths & Weaknesses
Table 4-3: GlaxoSmithKline plc - Strengths & Weaknesses
Table 4-4: Novartis International AG - Strengths & Weaknesses
Table 4-5: AstraZeneca Plc - Strengths & Weaknesse
